Bioxytran, Inc.
BIXT
$0.109
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.92M | -2.13M | -2.65M | -3.46M | -4.25M |
| Total Depreciation and Amortization | 7.80K | 7.90K | 8.80K | 9.10K | 9.80K |
| Total Amortization of Deferred Charges | 677.80K | 677.80K | 55.00K | 30.00K | 348.60K |
| Total Other Non-Cash Items | 780.40K | 399.10K | 354.10K | 663.40K | 608.60K |
| Change in Net Operating Assets | 1.31M | 952.30K | 2.01M | 2.16M | 2.58M |
| Cash from Operations | -147.50K | -89.80K | -226.50K | -599.30K | -698.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.30K | -28.30K | -22.80K | -26.40K | -45.60K |
| Cash from Investing | -22.30K | -28.30K | -22.80K | -26.40K | -45.60K |
| Total Debt Issued | 105.00K | 38.00K | 99.50K | 99.50K | 99.50K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 59.00K | 59.00K | 104.00K | 494.40K | 550.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -50.00K |
| Cash from Financing | 164.00K | 97.00K | 203.50K | 593.90K | 599.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.60K | -20.90K | -45.60K | -31.70K | -143.80K |